OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery Proteomics for COVID-19: Where We Are Now
Angela McArdle, Kirstin E. Washington, Blandine Chazarin Orgel, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 10, pp. 4627-4639
Open Access | Times Cited: 24

Showing 24 citing articles:

The 2022 Report on the Human Proteome from the HUPO Human Proteome Project
Gilbert S. Omenn, Lydie Lane, Christopher M. Overall, et al.
Journal of Proteome Research (2022) Vol. 22, Iss. 4, pp. 1024-1042
Open Access | Times Cited: 46

Clinical applications of plasma proteomics and peptidomics: Towards precision medicine
Bo He, Zhao Huang, Canhua Huang, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2022) Vol. 16, Iss. 6
Closed Access | Times Cited: 36

Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer’s and coronary disease pathways
Lihua Wang, Daniel Western, Jigyasha Timsina, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106408-106408
Open Access | Times Cited: 16

Assessment of Humoral Response at SARS-CoV-2 Infection by Multipronged Functional Proteomics Approaches
Pablo Juanes‐Velasco, Juan Carlos Pérez-Arévalo, Carlota Arias‐Hidalgo, et al.
Journal of Proteome Research (2025) Vol. 24, Iss. 2, pp. 515-525
Closed Access

Towards precision medicine: Omics approach for COVID-19
Xiaoping Cen, Feng-ao Wang, Xinhe Huang, et al.
Biosafety and Health (2023) Vol. 5, Iss. 2, pp. 78-88
Open Access | Times Cited: 11

Proteomic Analysis of Salivary Extracellular Vesicles from COVID-19 Patients Reveals a Specific Anti-COVID-19 Response Protein Signature
Laura Weber, Alfredo Torres, Ornella Realini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3704-3704
Open Access | Times Cited: 3

Plasma markers of COVID-19 severity: a pilot study
Julia Beimdiek, Sabina Janciauskiene, Sabine Wrenger, et al.
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 17

The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo
Lucía Beltrán-Camacho, Sara Eslava-Alcón, Marta Rojas-Torres, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 16

A two-gene marker for the two-tiered innate immune response in COVID-19 patients
Hongxing Lei
PLoS ONE (2023) Vol. 18, Iss. 1, pp. e0280392-e0280392
Open Access | Times Cited: 9

Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes
Laia Reverté, Elena Yeregui, Montserrat Olona, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 15

Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis
Fernando dos Santos, Joyce B. Li, Nathalia Juocys, et al.
Frontiers in Molecular Biosciences (2023) Vol. 9
Open Access | Times Cited: 7

Identification of SARS-CoV-2 Proteins from Nasopharyngeal Swabs Probed by Multiple Reaction Monitoring Tandem Mass Spectrometry
Gabriella Pinto, Anna Illiano, Veronica Ferrucci, et al.
ACS Omega (2021) Vol. 6, Iss. 50, pp. 34945-34953
Open Access | Times Cited: 14

Proteomic lung analysis revealed hyper-activation of neutrophil extracellular trap formation in cases of fatal COVID-19
Song Shu, Liyan Zeng, Jingjing Xu, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31878-e31878
Open Access | Times Cited: 1

Mass spectrometry and machine learning in the identification of COVID-19 biomarkers
Lucas C. Lázari, Gilberto Santos de Oliveira, Janaína Macedo-da-Silva, et al.
Frontiers in Analytical Science (2023) Vol. 3
Open Access | Times Cited: 3

Proteomic profiling identifies biomarkers of COVID-19 severity
Noa C. Harriott, Amy L. Ryan
Heliyon (2023) Vol. 10, Iss. 1, pp. e23320-e23320
Open Access | Times Cited: 3

HYGIEIA: HYpothesizing the Genesis of Infectious Diseases and Epidemics through an Integrated Systems Biology Approach
Bradley Ward, Jean Cyr Yombi, Jean‐Luc Balligand, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1373-1373
Open Access | Times Cited: 4

Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer and coronary disease pathways
Lihua Wang, Daniel Western, Jigyasha Timsina, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4

Proteomics research of SARS-CoV-2 and COVID-19 disease
Nan Zhang, Siyuan Wang, Catherine C. L. Wong
Medical Review (2022) Vol. 2, Iss. 4, pp. 427-445
Open Access | Times Cited: 4

“Multiomics” Approaches to Understand and Treat COVID-19: Mass Spectrometry and Next-Generation Sequencing
Diane Appiasie, Daniel J. Guerra, Kyle Tanguay, et al.
BioChem (2021) Vol. 1, Iss. 3, pp. 210-237
Open Access | Times Cited: 5

Proteomics and COVID-19: Recent Trends
Chandni Chandarana, Vipul Prajapati, Vidhi Vashi, et al.
(2024), pp. 283-306
Closed Access

Rise of the SARS-CoV-2 Variants: can proteomics be the silver bullet?
Arup Acharjee, Joshua Stephen Kingsly, Madhura Kamat, et al.
Expert Review of Proteomics (2022) Vol. 19, Iss. 3, pp. 197-212
Closed Access | Times Cited: 2

Dysregulation of circulating protease activity in Covid-19-associated superinfection
Fernando dos Santos, Joyce B. Li, Nathalia Juocys, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access

Page 1

Scroll to top